Patents
Patents for C07K - Peptides (3,738)
04/2010
04/14/2010CN101693672A Peptidomimetic protease inhibitors
04/13/2010US7695935 Using modified blood coagulation factor as therapeutic treatment for blood disorders and excessive bleeding due to tissue damage or trauma
04/08/2010DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors
04/06/2010US7691965 Helical synthetic peptides that stimulate cellular cholesterol efflux
04/06/2010US7691805 Antimicrobial compounds
04/06/2010US7691566 Compositions and methods for treatment of cancer
04/06/2010US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody
04/01/2010US20100081793 Therapeutic uses of humanized antibodies against alpha-4 integrin
03/2010
03/25/2010DE69029370C5 Erythropoietin-Isoformen Erythropoietin isoforms
03/24/2010CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine
03/23/2010US7683025 micelles; for loading or encapsulating polar drugs, DNA, mineralizable inorganic salts, and for small water-filled ion-conducting channels within their structure suitable for use in micro electromechanical devices,
03/18/2010US20100069299 Ghrelin analogs
03/18/2010US20100068218 Optimized Multi-Epitope Constructs and Uses Thereof
03/17/2010CN101670105A Humanized antibodies chelated with amylord beta peptide
03/16/2010US7678540 Biomimetic chemotaxis receptor-signal complex for use in identifying modulators of B-cell and T-cell receptor signaling pathways; immunotherapy
03/10/2010EP2161276A2 Methods, compositions and libraries pertaining PNA dimer and PNA oligomer systhesis
03/04/2010US20100056551 Anti-cancer cyclopenta [G] quinazoline compounds
03/04/2010US20100055120 Prostate stem cell antigen (psca) variants and subsequences thereof
03/03/2010EP2159230A1 Anti-TNF antibodies, compositions, methods and uses
02/2010
02/25/2010US20100048456 Glycopegylation methods and proteins/peptides produced by the methods
02/25/2010US20100047280 Flavivirus ns1 subunit vaccine
02/24/2010CN101654437A Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
02/23/2010US7666408 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage
02/16/2010US7662933 Pegylated granulocyte colony stimulating factor (G-CSF) to treat a hematopoietic disorder related to reduced neutrophil count, such as infectious disease, sepsis, or a result of radiotherapy or chemotherapy
02/16/2010US7662585 ErbB4 receptor-specific neuregulin related ligands and uses therefor
02/16/2010US7662554 Nucleic acid supported protein complementation
02/16/2010US7662388 Endogenous peptide and active subfragments thereof
02/16/2010US7662382 Inducible ligand for α1β1 integrin and uses
02/11/2010US20100034842 Compositions Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease
02/09/2010CA2378431C Peptides that lower blood glucose levels
02/02/2010US7655242 Defensin-inducing agents
02/02/2010CA2439051C Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
01/2010
01/27/2010CN101633689A Peptide selection method
01/27/2010CN101633636A Peptidomimetic protease inhibitors
01/27/2010CN100584950C Chimeric polypeptides and their use
01/21/2010DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter
01/20/2010EP1946109B1 Method for detecting autoantibodies formed in rheumatoid arthritis
01/20/2010EP1594529B1 Analogues of glp-1
01/20/2010EP1257649B1 Corynebacterium glutamicum genes encoding metabolic pathway proteins
01/14/2010US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction
01/06/2010EP2140878A1 Vaccine against streptococcus pneumoniae
12/2009
12/31/2009US20090325884 Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis
12/31/2009US20090325203 Assay For Tissue Factor And Factor Vlla
12/30/2009CN100575482C Novel cytokine zcytor17 ligand
12/30/2009CN100574840C Purification of immunoglobulins
12/29/2009US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/29/2009CA2300243C Process for preparing n-[5-(diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl]-n-methylmethanesulphonamide
12/23/2009CN100572390C Inhibitor of stem cell proliferation and uses thereof
12/22/2009US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/22/2009CA2133833C Method and kit for imaging and treating organs and tissues
12/16/2009CN101602807A Mammalian cytokines, reagent and method thereof
12/16/2009CN100569798C GLP-1 derivative
12/16/2009CN100569286C Attenuated strains of vibrio cholerae with freeze-dry type and modified biological security for orally inoculability
12/15/2009US7632816 Treatment of Alzheimer amyloid deposition
12/03/2009US20090297509 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
12/01/2009US7626031 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases
12/01/2009US7626012 Nucleic acids encoding monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
12/01/2009US7625861 Copolymer-1 improvements in compositions of copolymers
11/2009
11/26/2009US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity
11/25/2009EP2123665A2 Inhibitors of interleukin-1Beta converting enzyme
11/25/2009CN100562338C Beta-amyloid-analogue-cell epitop vaccine
11/24/2009US7622564 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697
11/24/2009US7622553 Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
11/24/2009CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/19/2009US20090286713 Collagen Receptor I-Domain Binding Modulators
11/19/2009US20090285835 Antibodies which bind human CXCR3
11/18/2009EP1575990B1 Solid phase bound PNA-dimers and their synthesis
11/17/2009US7618633 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
11/11/2009EP2116604A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
11/11/2009CN101575363A Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
11/05/2009US20090274717 Genes and proteins, and their use
11/03/2009US7612171 DB, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
11/03/2009US7611865 Genetic engineering
10/2009
10/29/2009US20090269619 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
10/28/2009EP2112161A2 Peptides that lower blood glucose levels
10/28/2009EP0983361B1 Bacterial pheromones and uses therefor
10/27/2009CA2539510C Size-controlled macromolecule
10/22/2009US20090263320 Peptide-Based Compounds
10/20/2009US7604932 And blood-coagulation factor VII using aminonapthalene sulfonamide-based fluorogenic substrates
10/07/2009CN101550190A An anti-il-12 antibody, a composition, a method and the function
10/06/2009US7597894 Antigen presenting cells and dendritic cells; inducing immunology response
10/01/2009US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009US20090247462 Fgf variants and methods for use thereof
09/2009
09/30/2009EP2105504A2 Genes and proteins, and their use
09/29/2009US7596455 Crystallization of IGF-1
09/29/2009US7595379 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697
09/24/2009US20090238821 Humanized antibodies that sequester amyloid beta peptide
09/23/2009EP1003781B1 Interleukin-18 binding proteins, their preparation and use
09/22/2009US7592171 Vibrio cholerae with improved biological safety features in freeze dried form
09/16/2009CN101531704A Peptide-based compounds
09/16/2009CN100540566C Analogues of GLP-1
09/15/2009US7589058 Ghrelin analogs
09/10/2009US20090227504 Pegylated Factor VII Glycoforms
09/10/2009US20090226505 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide
09/10/2009US20090226369 STQ Peptides
09/09/2009CN100537764C Metabolic protein for weed-control agent, its gene, and its use
09/08/2009US7585846 N-Acetyl L-Cysteine and L-Cysteine Choline Esters, and (R)-[2-(2,2-Dimethyl-thiazolidine-4-carbonyloxy)-ethyl]trimethyl-ammonium chloride, for example; compounds may be used to inhibit oxidative stress-induced cell injury or death both in vivo and ex vivo
09/02/2009CN101519449A Modified transferrin fusion proteins
09/01/2009US7582733 Modified immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy
09/01/2009US7582461 Kit for detection, monitoring kinase, phosphatase; mixture of peptides; detectable compound; adjustment proteolytic sensitivity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 38